protein biomarkers

Researchers showed it could differentiate pancreatic cancer cases from controls with high sensitivity, and believe it could work similarly for other cancers or in infectious disease.

The company said that it can distinguish patients suffering from lupus from those with other autoimmune diseases using its antibody array platform.

The company developed the instrument using in-licensed technology coupled with its own chemistry and other technology for exosomal protein analysis.

The team will use the new research grant to further develop the Stockholm3 prostate cancer test and to design follow-on diagnostics to help treat patients with the disease.

Three Markers

A Queen Mary University of London-led team reports on a three-protein biomarker panel for early stage pancreatic cancer.

The firm's approach builds on a pilot study for ISB's 100K Wellness Project, and study participants are invited to become customers.

Investigators from SomaLogic and elsewhere found proteins whose expression levels vary in Duchenne muscular dystrophy, often in conjunction with patients' age.

NEW YORK (GenomeWeb) – The plasma levels of a number of disease biomarkers are influenced by genetic and lifestyle factors, a new study in Nature Communications reported today.

NEW YORK (GenomeWeb) – The National Institutes of Health will award $1.5 million for research to find protein biomarkers that could be used to identify and treat chronic brain injuries (CBI), the long-term effects of traumatic brain injuries.

NEW YORK (GenomeWeb) — Data presented earlier this month at the 2014 European League Against Rheumatism (EULAR) Annual Congress by Crescendo Bioscience has added upon earlier retrospective data supporting the clinical utility of the company's Vectra DA test in measuring disease activity and predi

Pages

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.